Vaxxinity, Inc. (VAXX)
USD 0.05
(200.0%)
USD 0.05
(200.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 13.26 Million USD | 1.66% |
| 2022 | 13.04 Million USD | 26.37% |
| 2021 | 10.32 Million USD | -3.63% |
| 2020 | 10.71 Million USD | 832.29% |
| 2019 | 1.14 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | 13.26 Million USD | 10.73% |
| 2023 Q3 | 11.97 Million USD | -2.93% |
| 2023 Q1 | 12.69 Million USD | -2.69% |
| 2023 Q2 | 12.33 Million USD | -2.8% |
| 2023 FY | 13.26 Million USD | 1.66% |
| 2022 Q3 | 10.03 Million USD | -0.96% |
| 2022 Q1 | 10.22 Million USD | -0.94% |
| 2022 FY | 13.04 Million USD | 26.37% |
| 2022 Q4 | 13.04 Million USD | 30.03% |
| 2022 Q2 | 10.12 Million USD | -0.95% |
| 2021 Q3 | 10.36 Million USD | -0.9% |
| 2021 FY | 10.32 Million USD | -3.63% |
| 2021 Q1 | 10.55 Million USD | -1.47% |
| 2021 Q2 | 10.46 Million USD | -0.89% |
| 2021 Q4 | 10.32 Million USD | -0.41% |
| 2020 Q4 | 10.71 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 10.71 Million USD | 832.29% |
| 2019 FY | 1.14 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| America Great Health | 1.12 Million USD | -1080.799% |
| Ampio Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -926.471% |
| Biora Therapeutics, Inc. | 43.73 Million USD | 69.677% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -132520.0% |
| Better Therapeutics, Inc. | 10.34 Million USD | -28.16% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -9651.471% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -10923.923% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -52.577% |
| Evelo Biosciences, Inc. | 48.87 Million USD | 72.868% |
| Evolutionary Genomics, Inc. | 3.74 Million USD | -254.244% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | 53.308% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 91.22% |
| Innovation1 Biotech Inc. | 218.99 Thousand USD | -5955.735% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -1354.964% |
| Molecular Templates, Inc. | 9.74 Million USD | -36.132% |
| Navidea Biopharmaceuticals, Inc. | 1.87 Million USD | -608.548% |
| NexImmune, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | 30.445% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -216.214% |
| Point of Care Nano-Technology, Inc. | - USD | -Infinity% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | 87.289% |
| Statera Biopharma, Inc. | 11.43 Million USD | -16.016% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -1711.749% |
| Trevena, Inc. | 35.23 Million USD | 62.359% |
| Vaccinex, Inc. | 26 Thousand USD | -50907.692% |
| Vicapsys Life Sciences, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |